+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "CRISPR"

From
From
Gene Editing Tools Market - Product Thumbnail Image

Gene Editing Tools Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Gene Delivery Technologies Market - Product Thumbnail Image

Gene Delivery Technologies Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
MicroRNA Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

MicroRNA Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
Genomics Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Genomics Market - Forecasts from 2023 to 2028

  • Report
  • January 2023
  • 154 Pages
  • Global
From
Genome Editing Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Genome Editing Market - Forecasts from 2022 to 2027

  • Report
  • April 2022
  • 120 Pages
  • Global
From
CRISPR Market - Forecasts from 2021 to 2026 - Product Thumbnail Image

CRISPR Market - Forecasts from 2021 to 2026

  • Report
  • July 2021
  • 112 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population. The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more